3
Cellular Oncology 26 (2004) 353–354 353 IOS Press International Society for Cellular Oncology Citations that count, an editorial address to the ISCO membership Publications in biomedical science follow a vicious circle. The better the papers that are published in a journal, the more they are cited, the higher the impact factor of that journal will be, and thus the more at- tractive it is for authors of good papers to submit their manuscripts to that journal. Many members of ISCO are facing situations where impact factors of journals in which they publish have a major influence on their chances of successfully applying for research grants. In fact, this means that many of us not automatically will submit their manuscripts to a journal with an im- pact factor of 1.2, like Cellular Oncology. Despite this, the editor, associate editors and editorial board of Cel- lular Oncology have accepted the challenge to position Cellular Oncology as an attractive platform for pub- lishing scientific communications in the field of oncol- ogy. With the present issue we feel that we certainly have succeeded, and we want to stimulate you to help us succeed in the future as well. One way of doing this is by showing the ISCO members that Cellular Oncol- ogy papers, and in the past Analytical Cellular Pathol- ogy papers, have a potential of being cited quite well. To this end we here provide you with an overview of the most cited papers of the last five years, stratified by year. This proves that publishing in Cellular Oncology, which is listed in Medline, certainly is an excellent op- tion to reach a large readership. Gerrit A. Meijer Editor in chief Table 1 Most cited papers from Analytical Cellular Pathology over the last five years, stratified per year Year Ranking publication Times cited 1999 1 M. Leite et al. [1] 21 2 T. Gao et al. [2] 6 2 H. Illges et al. [3] 6 2 G. Tuccari et al. [4] 6 2 B. Nielsen et al. [5] 6 2 M. Aubele et al. [6] 6 2000 1 A. Alaiya et al. [7] 13 2 R. Heintzmann et al. [8] 11 3 V. Della Mea et al. [9] 10 4 C.L.M. Best et al. [10] 8 5 N.N. Wang et al. [11] 7 2001 1 G. Haroske et al. [12] 17 2 C. Lenander et al. [13] 14 3 M. Heiskanen et al. [14] 13 4 T.W. Remmerbach et al. [15] 9 5 I. Petersen et al. [16] 6 5 N.N. Wang et al. [17] 6 2002 1 M. Aubele et al. [18] 4 1 J. Smolle et al. [19] 4 3 T. Mattfeldt et al. [20] 3 3 H. Motherby et al. [21] 3 3 C. Wahlby et al. [22] 3 2003 1 K. Rodenacker et al. [23] 5 2 T.W. Remmerbach et al. [24] 4 3 A.O.H. Gerstner et al. [25] 3 4 H.J. Grote et al. [26] 2 4 T.W. Remmerbach et al. [27] 2 References [1] M. Leite, M. Quinta-Costa, P.S. Leite and J.E. Guimaraes, Crit- ical evaluation of techniques to detect and measure cell death – study in a model of UV radiation of the leukaemic cell line HL60, Anal. Cell. Pathol. 19 (1999), 139–151. 1570-5870/04/$17.00 2004 – IOS Press and the authors. All rights reserved

Citations that count, an editorial address to the ISCO ...354 International Society for Cellular Oncology [2] M. Aubele and M. Werner, Heterogeneity in breast cancer and the problem

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

  • Cellular Oncology 26 (2004) 353–354 353IOS Press

    International Society for Cellular Oncology

    Citations that count, an editorial address tothe ISCO membership

    Publications in biomedical science follow a viciouscircle. The better the papers that are published in ajournal, the more they are cited, the higher the impactfactor of that journal will be, and thus the more at-tractive it is for authors of good papers to submit theirmanuscripts to that journal. Many members of ISCOare facing situations where impact factors of journalsin which they publish have a major influence on theirchances of successfully applying for research grants.In fact, this means that many of us not automaticallywill submit their manuscripts to a journal with an im-pact factor of 1.2, like Cellular Oncology. Despite this,the editor, associate editors and editorial board of Cel-lular Oncology have accepted the challenge to positionCellular Oncology as an attractive platform for pub-lishing scientific communications in the field of oncol-ogy. With the present issue we feel that we certainlyhave succeeded, and we want to stimulate you to helpus succeed in the future as well. One way of doing thisis by showing the ISCO members that Cellular Oncol-ogy papers, and in the past Analytical Cellular Pathol-ogy papers, have a potential of being cited quite well.To this end we here provide you with an overview ofthe most cited papers of the last five years, stratified byyear. This proves that publishing in Cellular Oncology,which is listed in Medline, certainly is an excellent op-tion to reach a large readership.

    Gerrit A. MeijerEditor in chief

    Table 1

    Most cited papers from Analytical Cellular Pathology overthe last five years, stratified per year

    Year Ranking publication Times cited

    1999 1 M. Leite et al. [1] 21

    2 T. Gao et al. [2] 6

    2 H. Illges et al. [3] 6

    2 G. Tuccari et al. [4] 6

    2 B. Nielsen et al. [5] 6

    2 M. Aubele et al. [6] 6

    2000 1 A. Alaiya et al. [7] 13

    2 R. Heintzmann et al. [8] 11

    3 V. Della Mea et al. [9] 10

    4 C.L.M. Best et al. [10] 8

    5 N.N. Wang et al. [11] 7

    2001 1 G. Haroske et al. [12] 17

    2 C. Lenander et al. [13] 14

    3 M. Heiskanen et al. [14] 13

    4 T.W. Remmerbach et al. [15] 9

    5 I. Petersen et al. [16] 6

    5 N.N. Wang et al. [17] 6

    2002 1 M. Aubele et al. [18] 4

    1 J. Smolle et al. [19] 4

    3 T. Mattfeldt et al. [20] 3

    3 H. Motherby et al. [21] 3

    3 C. Wahlby et al. [22] 3

    2003 1 K. Rodenacker et al. [23] 5

    2 T.W. Remmerbach et al. [24] 4

    3 A.O.H. Gerstner et al. [25] 3

    4 H.J. Grote et al. [26] 2

    4 T.W. Remmerbach et al. [27] 2

    References

    [1] M. Leite, M. Quinta-Costa, P.S. Leite and J.E. Guimaraes, Crit-ical evaluation of techniques to detect and measure cell death– study in a model of UV radiation of the leukaemic cell lineHL60, Anal. Cell. Pathol. 19 (1999), 139–151.

    1570-5870/04/$17.00 2004 – IOS Press and the authors. All rights reserved

  • 354 International Society for Cellular Oncology

    [2] M. Aubele and M. Werner, Heterogeneity in breast cancer andthe problem of relevance of findings, Anal. Cell. Pathol. 19(1999), 53–58.

    [3] T.Y. Gao, J. Feng and Y.X. Ci, Human breast carcinomal tis-sues display distinctive FTIR spectra: implication for the his-tological characterization of carcinomas, Anal. Cell. Pathol. 18(1999), 87–93.

    [4] H. Illges, An automated 96-well-plate loader for the FACScan(R), Anal. Cell. Pathol. 19 (1999), 99–103.

    [5] B. Nielsen, F. Albregtsen and H.E. Danielsen, The use of frac-tal features from the periphery of cell nuclei as a classificationtool, Anal. Cell. Pathol. 19 (1999), 21–37.

    [6] G. Tuccari, J.A. Gimenez-Mas, F. Fedele, C. Del-Agua,B. Melcon, C.J. Trombetta and G. Giuffre, The AgNOR quan-tity as prognostic parameter in choroidal melanomas: a stan-dardised analysis, Anal. Cell. Pathol. 19 (1999), 163–168.

    [7] A. Alaiya, U. Roblick, L. Egevad, A. Carlsson, B. Franzen,D. Volz, S. Huwendiek, S. Linder and G. Auer, Polypeptide ex-pression in prostate hyperplasia and prostate adenocarcinoma,Anal. Cell. Pathol. 21 (2000), 1–9.

    [8] R. Heintzmann, G. Kreth and C. Cremer, Reconstruction ofaxial tomographic high resolution data from confocal fluores-cence microscopy: a method for improving 3D FISH images,Anal. Cell. Pathol. 20 (2000), 7–15.

    [9] V. Della Mea, P. Cataldi, B. Pertoldi and C.A. Beltrami, Com-bining dynamic and static robotic telepathology: a report on184 consecutive cases of frozen sections, histology and cytol-ogy, Anal. Cell. Pathol. 20 (2000), 33–39.

    [10] C.J.M. Best, J.W. Gillespie, C.R. Englert, J.I. Swalwell,J. Pfeifer, D.B. Krizman, E.F. Petricoin, L.A. Liotta and M.R.Emmert-Buck, New approaches to molecular profiling of tissuesamples, Anal. Cell. Pathol. 20 (2000), 1–6.

    [11] N.N. Wang, C. Wilkin, A. Bocking and B. Tribukait, Evalua-tion of tumor heterogeneity of prostate carcinoma by flow- andimage DNA cytometry and histopathological grading, Anal.Cell. Pathol. 20 (2000), 49–62.

    [12] G. Haroske, J.P.A. Baak, H. Danielsen, F. Giroud,A. Gschwendtner, M. Oberholzer, A. Reith, P. Spieler andA. Bocking, Fourth updated ESACP consensus report ondiagnostic DNA image cytometry, Anal. Cell. Pathol. 23(2001), 89–95.

    [13] C. Lenander, J. Habermann, A. Ost, B. Nilsson, H. Schim-melpenning, K. Tryggvason and G. Auer, Laminin-5 gamma 2chain expression correlates with unfavorable prognosis in coloncarcinomas, Anal. Cell. Pathol. 22 (2001), 201–209.

    [14] M. Heiskanen, J. Kononen, M. Barlund, J. Torhorst, G. Sauter,A. Kallioniemi and O. Kallioniemi, CGH, cDNA and tissuemicroarray analyses implicate FGFR2 amplification in a smallsubset of breast tumors, Anal. Cell. Pathol. 22 (2001), 229–234.

    [15] T.W. Remmerbach, H. Weidenbach, N. Pomjanski, K. Knops,S. Mathes, A. Hemprich and A. Bocking, Cytologic and DNA-

    cytometric early diagnosis of oral cancer, Anal. Cell. Pathol. 22(2001), 211–221.

    [16] I. Petersen and S. Petersen, Towards a genetic-based classifica-tion of human lung cancer, Anal. Cell. Pathol. 22 (2001), 111–121.

    [17] N.N. Wang, Q.M. He, S. Skog, S. Eriksson and B. Tribukait,Investigation on cell proliferation with a new antibody againstthymidine kinase 1, Anal. Cell. Pathol. 23 (2001), 11–19.

    [18] M. Aubele, G. Auer, H. Braselmann, J. Nahrig, H. Zitzels-berger, L. Quintanilla-Martinez, J. Smida, A. Walch, H. Hoflerand M. Werner, Chromosomal imbalances are associated withmetastasis-free survival in breast cancer patients, Anal. Cell.Pathol. 24 (2002), 77–87.

    [19] J. Smolle, A. Gerger, W. Weger, H. Kutzner and M. Tronnier,Tissue counter analysis of histologic sections of melanoma: In-fluence of mask size and shape, feature selection, statisticalmethods and tissue preparation, Anal. Cell. Pathol. 24 (2002),59–67.

    [20] T. Mattfeldt, H. Wolter, D. Trijic, H.W. Gottfried and H.A.Kestler, Chromosomal regions in prostatic carcinomas stud-ied by comparative genomic hybridization, hierarchical clusteranalysis and self-organizing feature maps, Anal. Cell. Pathol.24 (2002), 167–179.

    [21] H. Motherby, N. Pomjanski, M. Kube, A. Boros, T. Heiden,B. Tribukait and A. Bocking, Diagnostic DNA-flow-vs.-image-cytometry in effusion cytology, Anal. Cell. Pathol. 24 (2002),5–15.

    [22] C. Wahlby, J. Lindblad, M. Vondrus, E. Bengtsson andL. Bjorkesten, Algorithms for cytoplasm segmentation of fluo-rescence labelled cells, Anal. Cell. Pathol. 24 (2002), 101–111.

    [23] K. Rodenacker and E. Bengtsson, A feature set for cytometryon digitized microscopic images, Anal. Cell. Pathol. 25 (2003),1–36.

    [24] T.W. Remmerbach, H. Weidenbach, A. Hemprich and A. Bock-ing, Earliest detection of oral cancer using non-invasive brushbiopsy including DNA-image-cytometry: Report on four cases,Anal. Cell. Pathol. 25 (2003), 159–166.

    [25] A.O.H. Gerstner, J. Machlitt, H.J. Welkoborsky, F. Bootz andA. Tarnok, Analysis of ploidy in hypopharyngeal cancer bylaser scanning cytometry on fine needle aspirate biopsies, Anal.Cell. Pathol. 25 (2003), 51–62.

    [26] H.J. Grote, V. Schmiemann, M. Sarbia and A. Bocking, DNAextraction from bronchial aspirates for molecular cytology:Which method to take?, Anal. Cell. Pathol. 25 (2003), 83–88.

    [27] T.W. Remmerbach, H. Weidenbach, C. Muller, A. Hemprich,N. Pomjanski, B. Buckstegge and A. Bocking, Diagnosticvalue of nucleolar organizer regions (AgNORs) in brush biop-sies of suspicious lesions of the oral cavity, Anal. Cell. Pathol.25 (2003), 139–146.

  • Submit your manuscripts athttp://www.hindawi.com

    Stem CellsInternational

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    MEDIATORSINFLAMMATION

    of

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Behavioural Neurology

    EndocrinologyInternational Journal of

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Disease Markers

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    BioMed Research International

    OncologyJournal of

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Oxidative Medicine and Cellular Longevity

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    PPAR Research

    The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014

    Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Journal of

    ObesityJournal of

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Computational and Mathematical Methods in Medicine

    OphthalmologyJournal of

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Diabetes ResearchJournal of

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Research and TreatmentAIDS

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Gastroenterology Research and Practice

    Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

    Parkinson’s Disease

    Evidence-Based Complementary and Alternative Medicine

    Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com